- call +1-201-465-4211
- email sales@mrinsights.biz
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.
Scope of the Report:
This report studies the In situ Hybridization market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the In situ Hybridization market by product type and applications/end industries.
North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.
The global In situ Hybridization market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In situ Hybridization.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Roche
Thermo Fisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio Sb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization
Market Segment by Applications, can be divided into
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 In situ Hybridization Market Overview
1.1 Product Overview and Scope of In situ Hybridization
1.2 Classification of In situ Hybridization by Types
1.2.1 Global In situ Hybridization Revenue Comparison by Types (2017-2023)
1.2.2 Global In situ Hybridization Revenue Market Share by Types in 2017
1.2.3 Fluorescence In Situ Hybridization (FISH)
1.2.4 Chromogenic In Situ Hybridization
1.3 Global In situ Hybridization Market by Application
1.3.1 Global In situ Hybridization Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cancer Diagnosis
1.3.3 Immunology
1.3.4 Neuroscience
1.3.5 Cytology
1.3.6 Infectious Diseases
1.4 Global In situ Hybridization Market by Regions
1.4.1 Global In situ Hybridization Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) In situ Hybridization Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) In situ Hybridization Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In situ Hybridization Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) In situ Hybridization Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In situ Hybridization Status and Prospect (2013-2023)
1.5 Global Market Size of In situ Hybridization (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 In situ Hybridization Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 In situ Hybridization Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.3 Thermo Fisher Scientific
2.3.1 Business Overview
2.3.2 In situ Hybridization Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Thermo Fisher Scientific In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 In situ Hybridization Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.5 Agilent Technologies
2.5.1 Business Overview
2.5.2 In situ Hybridization Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Agilent Technologies In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.6 Perkin Elmer
2.6.1 Business Overview
2.6.2 In situ Hybridization Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Perkin Elmer In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.7 Danaher
2.7.1 Business Overview
2.7.2 In situ Hybridization Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Danaher In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.8 Exiqon
2.8.1 Business Overview
2.8.2 In situ Hybridization Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Exiqon In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biogenex Laboratories
2.9.1 Business Overview
2.9.2 In situ Hybridization Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biogenex Laboratories In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.10 Advanced Cell Diagnostics
2.10.1 Business Overview
2.10.2 In situ Hybridization Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Advanced Cell Diagnostics In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bio Sb
2.11.1 Business Overview
2.11.2 In situ Hybridization Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bio Sb In situ Hybridization Revenue, Gross Margin and Market Share (2016-2017)
3 Global In situ Hybridization Market Competition, by Players
3.1 Global In situ Hybridization Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 In situ Hybridization Players Market Share
3.2.2 Top 10 In situ Hybridization Players Market Share
3.3 Market Competition Trend
4 Global In situ Hybridization Market Size by Regions
4.1 Global In situ Hybridization Revenue and Market Share by Regions
4.2 North America In situ Hybridization Revenue and Growth Rate (2013-2018)
4.3 Europe In situ Hybridization Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific In situ Hybridization Revenue and Growth Rate (2013-2018)
4.5 South America In situ Hybridization Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa In situ Hybridization Revenue and Growth Rate (2013-2018)
5 North America In situ Hybridization Revenue by Countries
5.1 North America In situ Hybridization Revenue by Countries (2013-2018)
5.2 USA In situ Hybridization Revenue and Growth Rate (2013-2018)
5.3 Canada In situ Hybridization Revenue and Growth Rate (2013-2018)
5.4 Mexico In situ Hybridization Revenue and Growth Rate (2013-2018)
6 Europe In situ Hybridization Revenue by Countries
6.1 Europe In situ Hybridization Revenue by Countries (2013-2018)
6.2 Germany In situ Hybridization Revenue and Growth Rate (2013-2018)
6.3 UK In situ Hybridization Revenue and Growth Rate (2013-2018)
6.4 France In situ Hybridization Revenue and Growth Rate (2013-2018)
6.5 Russia In situ Hybridization Revenue and Growth Rate (2013-2018)
6.6 Italy In situ Hybridization Revenue and Growth Rate (2013-2018)
7 Asia-Pacific In situ Hybridization Revenue by Countries
7.1 Asia-Pacific In situ Hybridization Revenue by Countries (2013-2018)
7.2 China In situ Hybridization Revenue and Growth Rate (2013-2018)
7.3 Japan In situ Hybridization Revenue and Growth Rate (2013-2018)
7.4 Korea In situ Hybridization Revenue and Growth Rate (2013-2018)
7.5 India In situ Hybridization Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia In situ Hybridization Revenue and Growth Rate (2013-2018)
8 South America In situ Hybridization Revenue by Countries
8.1 South America In situ Hybridization Revenue by Countries (2013-2018)
8.2 Brazil In situ Hybridization Revenue and Growth Rate (2013-2018)
8.3 Argentina In situ Hybridization Revenue and Growth Rate (2013-2018)
8.4 Colombia In situ Hybridization Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue In situ Hybridization by Countries
9.1 Middle East and Africa In situ Hybridization Revenue by Countries (2013-2018)
9.2 Saudi Arabia In situ Hybridization Revenue and Growth Rate (2013-2018)
9.3 UAE In situ Hybridization Revenue and Growth Rate (2013-2018)
9.4 Egypt In situ Hybridization Revenue and Growth Rate (2013-2018)
9.5 Nigeria In situ Hybridization Revenue and Growth Rate (2013-2018)
9.6 South Africa In situ Hybridization Revenue and Growth Rate (2013-2018)
10 Global In situ Hybridization Market Segment by Type
10.1 Global In situ Hybridization Revenue and Market Share by Type (2013-2018)
10.2 Global In situ Hybridization Market Forecast by Type (2018-2023)
10.3 Fluorescence In Situ Hybridization (FISH) Revenue Growth Rate (2013-2023)
10.4 Chromogenic In Situ Hybridization Revenue Growth Rate (2013-2023)
11 Global In situ Hybridization Market Segment by Application
11.1 Global In situ Hybridization Revenue Market Share by Application (2013-2018)
11.2 In situ Hybridization Market Forecast by Application (2018-2023)
11.3 Cancer Diagnosis Revenue Growth (2013-2018)
11.4 Immunology Revenue Growth (2013-2018)
11.5 Neuroscience Revenue Growth (2013-2018)
11.6 Cytology Revenue Growth (2013-2018)
11.7 Infectious Diseases Revenue Growth (2013-2018)
12 Global In situ Hybridization Market Size Forecast (2018-2023)
12.1 Global In situ Hybridization Market Size Forecast (2018-2023)
12.2 Global In situ Hybridization Market Forecast by Regions (2018-2023)
12.3 North America In situ Hybridization Revenue Market Forecast (2018-2023)
12.4 Europe In situ Hybridization Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific In situ Hybridization Revenue Market Forecast (2018-2023)
12.6 South America In situ Hybridization Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa In situ Hybridization Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure In situ Hybridization Picture
Table Product Specifications of In situ Hybridization
Table Global In situ Hybridization and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
